All Episodes

September 8, 2022 42 mins

I had the pleasure to talk with Cal State Professor, Poet, Publisher, Author, and Cancer Survivor - Brad Buchanan.  We talked about his fourth book(second book on Finishing line Press), Chimera.  Plus, we discussed his previous books(The Miracle Shirker, Swimming the Mirror, and the Scars, Aligned), being a professor at Sacramento State University, being a Book publisher and owner with Roan Press, and his journey being diagnosed with Lymphoma in 2015. He has been in remission but he experience several complications.  Finally, he recites a poem from the new book to his late mother.

Preorder your copy of Chimera: click here

Social Media

Brad Buchanan - his Website

CharRon Smith - Iambiczine

Mark as Played

Advertise With Us

Popular Podcasts

I Do, Part 2

I Do, Part 2

From Executive Producers Jennie Garth, Jana Kramer, Amy Robach, and T.J. Holmes. Did you think you met the love of your life and marry him, only to realize it was actually “thank you, next?" Did this jerk cheat on you and leave you feeling alone and hopeless? Don’t make the same mistake twice... Get it right THIS time! Is it time to find true love…again?! If you loved the Golden Bachelor, SILVER just might be your color. Older and wiser, 50 and Fabulous, and ready for a little sex in the city. Everyone has baggage, but you’re not bringing it on this trip. Second Times The Charm. I Do, Part Two. An iHeartRadio podcast...where finding love is the main objective.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

The Bobby Bones Show

The Bobby Bones Show

Listen to 'The Bobby Bones Show' by downloading the daily full replay.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.